Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Glimepiride (Sulfonylurea)
Treatment for Diabetes mellitus type 2
Typical Dosage: 1-8 mg daily
Effectiveness
82%
Safety Score
60%
Clinical Trials
61
Participants
400K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
1-8 mg daily
Time to Effect
Days to 1-2 weeks
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
35(Treat 35 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$450
Side Effect Mgmt:$100
Total Annual:$625
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$25,000/QALY
QALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$801.28
Cost per Remission
$20,833.33
Comparison vs Metformin
Cost Difference
+$110/year
More expensive
QALY Difference
-0.05 QALYs
Worse outcomes
Dominance
No dominance
Glimepiride (Sulfonylurea) Outcomes
for Diabetes mellitus type 2
Efficacy Outcomes
Overall Effectiveness
+82%
Response Rate
+78%
Remission Rate
+3%
Common Side Effects
Hypoglycemia
+12%
Weight gain
+3%
Nausea/Diarrhea
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
18 completed trials for Glimepiride (Sulfonylurea) in Diabetes mellitus type 2
CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride
NCT00968812COMPLETEDPHASE3
1.45K participants
INTERVENTIONAL
Calera, United States +137 more
Started: Sep 1, 2009
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients
NCT01242215COMPLETEDPHASE3
243 participants
INTERVENTIONAL
Chugoku, Japan +6 more
Started: Sep 17, 2010
Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
NCT01340768COMPLETEDPHASE3
870 participants
INTERVENTIONAL
Started: Jun 22, 2010
Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes
NCT00974090COMPLETEDPHASE3
194 participants
INTERVENTIONAL
Sapporo, Japan
Started: Sep 1, 2009
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
NCT02312063COMPLETEDPHASE4
48 participants
INTERVENTIONAL
Osaka, Japan +1 more
Started: Feb 1, 2015
Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan
NCT01318083COMPLETEDPHASE2, PHASE3
312 participants
INTERVENTIONAL
Started: Aug 1, 2008
How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.
NCT00747383COMPLETEDNA
74 participants
INTERVENTIONAL
Bournemouth, United Kingdom
Started: Sep 1, 2008
Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
NCT01769378COMPLETEDPHASE3
300 participants
INTERVENTIONAL
Chino, United States +30 more
Started: Jan 1, 2013
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
NCT00379769COMPLETEDPHASE3
4.45K participants
INTERVENTIONAL
Miranda, Australia +445 more
Started: Apr 1, 2001
Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)
NCT00708578COMPLETEDPHASE4
99 participants
INTERVENTIONAL
Seoul, South Korea
Started: May 1, 2008
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
NCT03983551COMPLETEDPHASE4
101 participants
INTERVENTIONAL
Started: Mar 1, 2016
The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes
NCT01404676COMPLETEDPHASE4
34 participants
INTERVENTIONAL
Seoul, South Korea
Started: Jun 1, 2010
A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)
NCT00792935COMPLETEDPHASE2
143 participants
INTERVENTIONAL
Started: Jan 1, 2009
Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
NCT00562172COMPLETEDPHASE4
75 participants
INTERVENTIONAL
Seoul, South Korea
Started: Sep 1, 2007
An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
NCT01357135COMPLETED
3.45K participants
OBSERVATIONAL
Started: Jul 15, 2009
Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan
NCT01318135COMPLETEDPHASE2, PHASE3
576 participants
INTERVENTIONAL
Started: Jan 1, 2009
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
NCT01584232COMPLETEDPHASE3
361 participants
INTERVENTIONAL
Aichi, Japan +14 more
Started: Apr 1, 2012
Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
NCT01131182COMPLETEDPHASE4
1.15K participants
INTERVENTIONAL
Started: Jun 13, 2010
Showing 20 of 62 total trials